Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Target (United States) · Celltechgen (United States) · +2 more institutions
Indexed incrossrefdoajpubmed
Abstract
No abstract available for this paper.
Citation impact
1,110
total citations
- FWCI
- 7.10
- Percentile
- 100%
- References
- 82
Citations per year
Authors
13- DGD. G. WinklerCorresponding
Target (United States), Celltechgen (United States)
- MKMay Kung Sutherland
Target (United States), Celltechgen (United States)
- JCJames C. Geoghegan
Target (United States), Celltechgen (United States)
- CYChangpu Yu
Target (United States), Celltechgen (United States)
- THTrenton Hayes
Target (United States), Celltechgen (United States)
Topics & keywords
Keywords
- Sclerostin
- Osteocyte
- Bone morphogenetic protein
- Osteoblast
- Endocrinology
- Internal medicine
- Bone morphogenetic protein 7
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.